Utility of Combination Therapy with Mood Stabilizers and Antipsychotics in Bipolar Disorder
NQ Score
42/100
N1 Content Completeness
5
AI Summary (NQ-processed)
A research group led by Professor Tadashi Kato of Juntendo University and Representative Director Yasuyuki Okumura of the Clinical Epidemiology Research Promotion Organization comprehensively investigated the recurrence prevention effects of monotherapy and combination therapy with mood stabilizers and antipsychotics for bipolar disorder, using the National Database of Health Insurance Claims and Specific Health Checkups (NDB) held by the Ministry of Health, Labour and Welfare. It was revealed that combination therapy, particularly with lithium carbonate and certain other drugs, further reduces hospitalization risk compared to monotherapy.